| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $510.2M | +19.6% |
| Cost of Revenue | $217.4M | +5.1% |
| Gross Profit | $292.8M | +33.3% |
| R&D Expense | $4.8M | +162.7% |
| SG&A Expense | $91.6M | +23.5% |
| Operating Income | $191.4M | +37.7% |
| Pre-tax Income | $182.7M | +45.3% |
| Income Tax | $35.7M | +149.6% |
| Net Income | $146.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.6M | -15.0% |
| Accounts Receivable | $158.4M | +216.9% |
| Inventory | $206.5M | +21.3% |
| Current Assets | $466.5M | +40.8% |
| Total Assets | $624.2M | +27.7% |
| Current Liabilities | $69.5M | +25.2% |
| Long-term Debt | $72.1M | -0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.4M | -57.5% |
| Capital Expenditures | $22.6M | +174.4% |
| Investing Cash Flow | -$21.9M | -155.3% |
| Financing Cash Flow | -$44.0M | +24.5% |
| Free Cash Flow | $27.8M | -74.8% |
| -25.7% |
| EPS (Basic) | $0.62 | -27.1% |
| EPS (Diluted) | $0.60 | -25.9% |
| Total Liabilities |
| $146.9M |
| +5.2% |
| Stockholders' Equity | $477.3M | +36.8% |